Get the Stockscreener App
3.25
11.44%
-0.42
After Hours:
3.20
-0.05
-1.54%
Briacell Therapeutics Corp Stock (BCTX) Latest News
BCTX stock touches 52-week low at $3.31 amid sharp annual decline By Investing.com - Investing.com South Africa
BriaCell Therapeutics Corp. (NASDAQ:BCTX) Sees Significant Increase in Short Interest - Defense World
BriaCell Therapeutics (NASDAQ:BCTX) versus Actinium Pharmaceuticals (NYSE:ATNM) Critical Analysis - Defense World
(BCT) Equity Trading Insights (BCT:CA) - Stock Traders Daily
(BCT) Market Performance Analysis (BCT:CA) - Stock Traders Daily
BriaCell Therapeutics Corp (NASDAQ: BCTX) – An Analysis Is What You Need - Stocks Register
(BCT) Investment Analysis (BCT:CA) - Stock Traders Daily
(BCT) Trading Advice (BCT:CA) - Stock Traders Daily
BriaCell Therapeutics: A Biotech Stock on the Brink of a Turnaround? - HPBL
Biotechs on the Brink: 2 Stocks With Huge Potential - MarketBeat
BriaCell regains Nasdaq compliance with bid price By Investing.com - Investing.com Australia
BriaCell regains Nasdaq compliance with bid price - MSN
Briacell Therapeutics CorpRegains Compliance With Nasdaq Minimum Bid Price Requirement - Marketscreener.com
BriaCell Announces Positive Shareholder Meeting Results - MSN
BriaCell announces public offering of common shares By Investing.com - Investing.com Nigeria
BriaCell Therapeutics (NASDAQ:BCTXW) Trading Up 0.2% – Time to Buy? - Defense World
BriaCell Therapeutics Closes Public Offering, Raises $3.05 MillionUnited States Securities and Exchange Commission, Washington, D.C. – February 3, 2025, BriaCell Therapeutics Corp. recently concluded a successful public offering. The Canadian biotech - Armenian Reporter
Equities Analysts Set Expectations for TSE:BCT Q2 Earnings - MarketBeat
BriaCell announces public offering of common shares - MSN
BriaCell immunotherapy destroys metastatic breast cancer tumor - MSN
BriaCell Therapeutics (NASDAQ:BCTX) Price Target Raised to $32.00 - Armenian Reporter
HC Wainwright Has Bullish Estimate for BCTX Q2 Earnings - Defense World
HC Wainwright Has Bullish Forecast for TSE:BCT Q2 Earnings - Defense World
BriaCell Therapeutics Announces Closing of Public Offering - GlobeNewswire
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting - GlobeNewswire
BriaCell's Board Secures Massive 88% Shareholder Approval at Annual Meeting - StockTitan
BriaCell Therapeutics Secures $3.05 Million in Public Offering - TipRanks
Briacell Therapeutics Announces Closing Of Public Offering -February 05, 2025 at 04:19 pm EST - Marketscreener.com
BriaCell Therapeutics Announces Closing of Public Offering - Benzinga
Cancer Immunotherapy Pioneer BriaCell Secures Critical $3.05M Funding to Advance Treatment Development - StockTitan
BriaCell Therapeutics stock rises on positive clinical trial results - MSN
United Therapeutics president sells $3.5m in stock - MSN
BriaCell Stock Climbs After ‘Unprecedented’ Immunotherapy Response In Breast Cancer Patient, Retail Exudes Optimism - MSN
BriaCell immunotherapy destroys metastatic breast cancer tumor | 2025-02-03 | Investing News - Stockhouse Publishing
H.C. Wainwright raises Briacell stock target to $32 on trial success - Investing.com
BriaCell Therapeutics (NASDAQ:BCTX) Given New $32.00 Price Target at HC Wainwright - Defense World
BriaCell Therapeutics slumps 20%, prices $3M stock offering - MSN
ForexTV | Small Business Resources - ForexTV.com
BriaCell Therapeutics Announces $3.05 Million Public Offering - TipRanks
Briacell Therapeutics Prices Public Offering Of 762,500 Shares At $4 Each -February 03, 2025 at 08:04 pm EST - Marketscreener.com
BriaCell's $3.05M Capital Raise: Strategic Move or Dilution Concern? - StockTitan
Wavelo Secures Four-Year Contract Renewal with EchoStar - The Globe and Mail
BriaCell Therapeutics Announces Pricing of Public Offering - Yahoo Finance
BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™ - GlobeNewswire
Briacell Therapeutics Announces Proposed Public Offering Of Common Shares -February 03, 2025 at 05:36 pm EST - Marketscreener.com
BriaCell Therapeutics Shares Hit Record Low After Public Offering News - MarketWatch
BriaCell Therapeutics Announces Public Offering to Fuel Growth - TipRanks
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):